(2026). A SUMOylation/immune-related gene signature predicts the prognosis and immunotherapy efficacy of patients with triple-negative breast cancer. PeerJ.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"A SUMOylation/immune-related Gene Signature Predicts the Prognosis and Immunotherapy Efficacy of Patients with Triple-negative Breast Cancer."
PeerJ 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"A SUMOylation/immune-related Gene Signature Predicts the Prognosis and Immunotherapy Efficacy of Patients with Triple-negative Breast Cancer."
PeerJ, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.